Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spectocor was a U.S.-based healthcare company focused on remote cardiac monitoring and diagnostic testing services rather than drug development. The company marketed and provided ambulatory cardiac monitoring solutions, including Pocket ECG-based monitoring services spanning Holter, event, and telemetry-style offerings. Public records identify Spectocor as also operating under the name AMI Monitoring Inc. and describe its business activities from 2011 through 2016 in cardiac monitoring reimbursement and service delivery. More recent third-party business databases describe the company as inactive or "deadpooled," suggesting it is no longer operating as an active independent business. It is healthcare-related, but it is not a biotech or therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spectocor.